Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 - GlobalData

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 - GlobalData
Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Published Oct 01, 2016
118 pages — Published Oct 01, 2016
Price US$ 4,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016' provides an overview of Human Papillomavirus Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Human Papillomavirus Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Human Papillomavirus Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Human Papillomavirus Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Human Papillomavirus Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0227EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents28
  1.1 List of Tables54
  1.2 List of Figures91
2 Introduction101
  2.1 Human Papillomavirus Diagnostic Tests Overview101
3 Products under Development115
  3.1 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development111
  3.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Territory121
  3.3 Human Papillomavirus Diagnostic Tests - Pipeline Products by Regulatory Path131
  3.4 Human Papillomavirus Diagnostic Tests - Pipeline Products by Estimated Approval Date141
  3.5 Human Papillomavirus Diagnostic Tests - Ongoing Clinical Trials151
4 Human Papillomavirus Diagnostic Tests - Pipeline Products under Development by Companies164
  4.1 Human Papillomavirus Diagnostic Tests Companies - Pipeline Products by Stage of Development162
  4.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development182
5 Human Papillomavirus Diagnostic Tests Companies and Product Overview2074
  5.1 AutoGenomics, Inc. Company Overview201
    5.1.1 AutoGenomics, Inc. Pipeline Products &Ongoing Clinical Trials Overview203
  5.2 Beckman Coulter, Inc. Company Overview231
    5.2.1 Beckman Coulter, Inc. Pipeline Products &Ongoing Clinical Trials Overview231
  5.3 Becton, Dickinson and Company Company Overview241
    5.3.1 Becton, Dickinson and Company Pipeline Products &Ongoing Clinical Trials Overview242
  5.4 Biocartis SA Company Overview261
    5.4.1 Biocartis SA Pipeline Products &Ongoing Clinical Trials Overview261
  5.5 Biomagnetics Diagnostics Corporation (Inactive) Company Overview271
    5.5.1 Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products &Ongoing Clinical Trials Overview271
  5.6 Bioorganic Research and Services S.A. Company Overview281
    5.6.1 Bioorganic Research and Services S.A. Pipeline Products &Ongoing Clinical Trials Overview282
  5.7 Bio-Techne Corp Company Overview301
    5.7.1 Bio-Techne Corp Pipeline Products &Ongoing Clinical Trials Overview303
  5.8 Cepheid Company Overview331
    5.8.1 Cepheid Pipeline Products &Ongoing Clinical Trials Overview332
  5.9 China Medical Technologies, Inc. Company Overview351
    5.9.1 China Medical Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview352
  5.10 Chronix Biomedical, Inc. Company Overview371
    5.10.1 Chronix Biomedical, Inc. Pipeline Products &Ongoing Clinical Trials Overview371
  5.11 Co-Diagnostics HBDC, Inc. Company Overview381
    5.11.1 Co-Diagnostics HBDC, Inc. Pipeline Products &Ongoing Clinical Trials Overview381
  5.12 Enigma Diagnostics Limited Company Overview391
    5.12.1 Enigma Diagnostics Limited Pipeline Products &Ongoing Clinical Trials Overview391
  5.13 Enzo Life Sciences, Inc. Company Overview401
    5.13.1 Enzo Life Sciences, Inc. Pipeline Products &Ongoing Clinical Trials Overview401
  5.14 Genera Biosystems Limited Company Overview411
    5.14.1 Genera Biosystems Limited Pipeline Products &Ongoing Clinical Trials Overview413
  5.15 German Cancer Research Center Company Overview441
    5.15.1 German Cancer Research Center Pipeline Products &Ongoing Clinical Trials Overview442
  5.16 Goodgene Inc Company Overview461
    5.16.1 Goodgene Inc Pipeline Products &Ongoing Clinical Trials Overview461
  5.17 Great Basin Corporation Company Overview471
    5.17.1 Great Basin Corporation Pipeline Products &Ongoing Clinical Trials Overview472
  5.18 HEALTH BioMed Co., Ltd. Company Overview491
    5.18.1 HEALTH BioMed Co., Ltd. Pipeline Products &Ongoing Clinical Trials Overview491
  5.19 Homepoint Testing Company Overview501
    5.19.1 Homepoint Testing Pipeline Products &Ongoing Clinical Trials Overview501
  5.20 IncellDx, Inc. Company Overview511
    5.20.1 IncellDx, Inc. Pipeline Products &Ongoing Clinical Trials Overview512
  5.21 KogeneBiotech Co Ltd Company Overview531
    5.21.1 KogeneBiotech Co Ltd Pipeline Products &Ongoing Clinical Trials Overview531
  5.22 MEDITE Cancer Diagnostics, Inc. Company Overview541
    5.22.1 MEDITE Cancer Diagnostics, Inc. Pipeline Products &Ongoing Clinical Trials Overview542
  5.23 MedNostic Technologies, LLC Company Overview561
    5.23.1 MedNostic Technologies, LLC Pipeline Products &Ongoing Clinical Trials Overview561
  5.24 Molbio Diagnostics Pvt. Ltd. Company Overview571
    5.24.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products &Ongoing Clinical Trials Overview571
  5.25 New Mexico Cancer Care Alliance Company Overview581
    5.25.1 New Mexico Cancer Care Alliance Pipeline Products &Ongoing Clinical Trials Overview584
  5.26 Novacyt Company Overview621
    5.26.1 Novacyt Pipeline Products &Ongoing Clinical Trials Overview622
  5.27 OncoHealth Corporation Company Overview641
    5.27.1 OncoHealth Corporation Pipeline Products &Ongoing Clinical Trials Overview642
  5.28 Pathogenica, Inc. Company Overview661
    5.28.1 Pathogenica, Inc. Pipeline Products &Ongoing Clinical Trials Overview661
  5.29 Provista Diagnostics Inc. Company Overview671
    5.29.1 Provista Diagnostics Inc. Pipeline Products &Ongoing Clinical Trials Overview672
  5.30 Quidel Corporation Company Overview691
    5.30.1 Quidel Corporation Pipeline Products &Ongoing Clinical Trials Overview692
  5.31 Rheonix, Inc. Company Overview711
    5.31.1 Rheonix, Inc. Pipeline Products &Ongoing Clinical Trials Overview711
  5.32 Roche Diagnostics International Ltd. Company Overview721
    5.32.1 Roche Diagnostics International Ltd. Pipeline Products &Ongoing Clinical Trials Overview723
  5.33 Roche Molecular Systems, Inc. Company Overview751
    5.33.1 Roche Molecular Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview752
  5.34 Sansure Biotech Inc Company Overview771
    5.34.1 Sansure Biotech Inc Pipeline Products &Ongoing Clinical Trials Overview772
  5.35 Seattle Children s Research Institute Company Overview791
    5.35.1 Seattle Children s Research Institute Pipeline Products &Ongoing Clinical Trials Overview791
  5.36 Seegene, Inc. Company Overview801
    5.36.1 Seegene, Inc. Pipeline Products &Ongoing Clinical Trials Overview802
  5.37 Sequenom, Inc. Company Overview821
    5.37.1 Sequenom, Inc. Pipeline Products &Ongoing Clinical Trials Overview823
  5.38 The Feinstein Institute for Medical Research Company Overview851
    5.38.1 The Feinstein Institute for Medical Research Pipeline Products &Ongoing Clinical Trials Overview851
  5.39 The University of Queensland Company Overview861
    5.39.1 The University of Queensland Pipeline Products &Ongoing Clinical Trials Overview861
  5.40 TrovaGene, Inc. Company Overview871
    5.40.1 TrovaGene, Inc. Pipeline Products &Ongoing Clinical Trials Overview872
  5.41 University of Texas at Austin Company Overview891
    5.41.1 University of Texas at Austin Pipeline Products &Ongoing Clinical Trials Overview891
  5.42 ValiRx Plc Company Overview901
    5.42.1 ValiRx Plc Pipeline Products &Ongoing Clinical Trials Overview902
  5.43 Yale University Company Overview921
    5.43.1 Yale University Pipeline Products &Ongoing Clinical Trials Overview922
6 Human Papillomavirus Diagnostic Tests - Recent Developments9421
  6.1 Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016942
  6.2 Sep 13, 2016: ValiRx: Quarterly Update On Clinical Developments961
  6.3 Sep 06, 2016: BD Submits Pre-Market Approval Application to FDA for BD Onclarity HPV Test971
  6.4 Sep 02, 2016: Danaher to Acquire Cepheid971
  6.5 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments981
  6.6 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter991
  6.7 Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-20171003
  6.8 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors1031
  6.9 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results1041
  6.10 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 20161042
  6.11 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results1061
  6.12 Jul 11, 2016: David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business1071
  6.13 Jul 06, 2016: Bio-Techne Acquires Advanced Cell Diagnostics1081
  6.14 Jul 04, 2016: Exiqon Nomination of candidates for the supervisory board1081
  6.15 Jun 21, 2016: Genera Biosystems provides update on PapType HPV test1081
  6.16 May 25, 2016: MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing1091
  6.17 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results1091
  6.18 May 09, 2016: Novacyt Enters into Clinical Trial Agreement with St Stephen s AIDS Trust1101
  6.19 Feb 15, 2016: Novacyt to Collaborate to Validate HPV Testing with NOVAprep Technology1101
  6.20 Feb 03, 2016: NEUMANN Diagnostics automated cervical cancer test achieves exceptional accuracy1111
  6.21 Feb 01, 2016: Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening1111
  6.22 Jan 04, 2016: Seegene s HPV DNA assay proves its excellent performance in WHO global HPV LabNet study1121
  6.23 Nov 12, 2015: New Modeling Analysis Shows Screening for Cervical Cancer with Pap+HPV Together Could Provide Better Clinical and Economic Outcomes than Screening with HPV Alone1122
  6.24 Oct 12, 2015: Roche Wins the first HPV Primary Screening Tender in Europe1141
7 Appendix1154
  7.1 Methodology1152
  7.2 About GlobalData1171
  7.3 Contact Us1171
  7.4 Disclaimer1181

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" Oct 01, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Human-Papillomavirus-Diagnostic-Tests-Medical-Devices-Pipeline-Assessment-2016-2085-23755>
  
APA:
GlobalData. (2016). Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Oct 01, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Human-Papillomavirus-Diagnostic-Tests-Medical-Devices-Pipeline-Assessment-2016-2085-23755>
  
US$ 4,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.